An Analysis of IPMN and Pancreatic Cancer Outcomes

June 14, 2014

Tanios Bekaii-Saab, MD, Section Chief, Gastrointestinal Oncology, associate professor, Internal Medicine, Pharmacology, The Ohio State University, discusses an analysis of IPMN and pancreatic cancer.

Clinical Pearls

Tanios Bekaii-Saab, MD, Section Chief, Gastrointestinal Oncology, associate professor, Internal Medicine, Pharmacology, The Ohio State University, discusses an analysis of IPMN and pancreatic cancer.

  • This analysis looked at the outcomes of patients with IPMN in the background of pancreatic cancer.
  • It has been known that patients with IPMN do better than those with pancreatic cancer.
  • Researchers hope that this data can help to identify and stratify patients to improve outcomes.